Land: Australia
Språk: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
Betamethasone dipropionate
Merck Sharp & Dohme Australia Pty Ltd
Medicine Registered
ELEUPHRAT ® _Betamethasone dipropionate_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Eleuphrat. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using Eleuphrat against the benefits it is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT ELEUPHRAT IS USED FOR The name of your medicine is Eleuphrat. It contains the active ingredient called betamethasone dipropionate. It is a type of cortisone and belongs to the group of medicines called corticosteroids. Eleuphrat is classified as a high potency topical corticosteroid. There are two forms of Eleuphrat: cream and ointment Eleuphrat is used on the skin to relieve the redness, swelling, itching and discomfort of many skin problems such as: • psoriasis (a stubborn skin disorder with raised, rough, reddened areas covered with dry, fine silvery scales) • eczema (an often itchy skin condition with redness, swelling, oozing of fluid, crusting which may lead to scaling) • other types of dermatitis Your doctor may have prescribed Eleuphrat for another reason. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY ELEUPHRAT HAS BEEN PRESCRIBED FOR YOU. This medicine is available only with a doctor's prescription. BEFORE YOU USE ELEUPHRAT _WHEN YOU MUST NOT USE IT_ DO NOT USE ELEUPHRAT IF YOU HAVE HAD AN ALLERGIC REACTION (SUCH AS WHEEZING, RASH OR HIVES) TO: • BETAMETHASONE DIPROPIONATE • ANY OTHER CORTICOSTEROID • ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET DO NOT USE ELEUPHRAT IF YOU HAVE: • A VIRAL SKIN INFECTION, SUCH AS COLD SORES, SHINGLES OR CHICKEN POX • A FUNGAL SKIN INFECTION, SUCH AS THRUSH, TINEA OR RINGWORM • TUBERCULOSIS OF THE SKIN • ACNE ROSACEA • INFLAMMATION AROUND THE MOUTH • S Les hele dokumentet
PI ref.: A110922Version 3 1 PRODUCT INFORMATION ELEUPHRAT CREAM, OINTMENT AND LOTION NAME OF THE MEDICINE Betamethasone dipropionate equivalent to betamethasone 0.5 mg/g (0.05% w /w ) Chemical Structure: Betamethasone dipropionate is 9-fluoro-11 β,17,21-trihydroxy-16β-methylpregna-1,4-diene- 3,20-dione 17,21-dipropionate. The empirical formula is C 28 H 37 FO 7 . MW = 504.6 DESCRIPTION ELEUPHRAT CREAM (0.05% w /w ): Each g contains betamethasone dipropionate equivalent to betamethasone 0.5 mg. The cream base consists of chlorocresol 1 mg/g as preservative, soft w hite paraffin, liquid paraffin, cetostearyl alcohol, cetomacrogol 1000, sodium phosphate monobasic, phosphoric acid and purified w ater. ELEUPHRAT OINTMENT (0.05% w /w ): Each g contains betamethasone dipropionate equivalent to betamethasone 0.5 mg in an ointment base consisting of soft w hite paraffin and liquid paraffin. ELEUPHRAT LOTION (0.05% w /w ): Each mL contains betamethasone dipropionate equivalent to betamethasone 0.47 mg in a vehicle consisting of isopropyl alcohol, carbomer 934P, sodium hydroxide and purified w ater. PHARMACOLOGY Betamethasone dipropionate is a potent topically-active corticosteroid producing prompt, marked and prolonged anti-inflammatory, anti-pruritic and vasoconstrictive effects. According to the McKenzie-Stoughton Vasoconstrictor Test, betamethasone dipropionate w as demonstrated to be significantly more active (p< 0.05) than betamethasone valerate, fluocortolone, and flumethasone pivalate. While the direct applicability of this vasoconstrictor test to clinical situations has not been demonstrated conclusively, the results show ed betamethasone dipropionate to be active in a concentration of 0.000016% , the low est concentration tested Les hele dokumentet